?>

Work with an Experienced Medical Malpractice Lawyer

We provide a wide variety of services to our business clients ranging from the preparation of agreements or contracts to the sale or purchase of businesses to employee relations or business dissolution. A penny spent now can save many dollars later! Let the Brad Hendricks Law Firm provides knowledgeable and sound legal advice concerning your business needs.

Starting in 2013, the FDA approved the SLGT2 inhibitor drug, Invokana, that treats type 2 diabetes and, until 2015, has seen over one hundred  claims that the drug has elicited adverse effects on patients’ health. The most serious potential side effects and risks caused by Invokana are myocardial infarction (heart attack), kidney damage, and ketoacidosis.

With over 70 percent of these plaintiffs’ experiences resulting in hospitalizations or intensive care, 50 percent of them experienced any of the above symptoms within the first thirty days of taking the drug. The controversy and concern circling the SLGT2 inhibitor is that the drug manufacturers, J&J and its Janssen Pharmaceuticals unit, did not properly warn physicians and/or patients of the potential risks associated with the drug.

On May 20, 2016, Janssen updated Invokana’s warning label to include the risk of diabetic ketoacidosis (DKA) associated with use of Invokana. Previously, in May 2015, the FDA alerted the public to the risk of diabetic ketoacidosis (DKA) associated with the use of drugs like Invokana and then required the manufacturers of all drugs in the class to update the warning sections to include DKA in December 2015.

A majority of the claims have roots in the fact that had physicians and patients been adequately made aware of these health risks, they’d have opted to take a different drug to treat type 2 diabetes or would have more closely monitored their health, thus alleviating themselves of any of the subsequent harm linked to the medication.

There are other drugs that are associated with these lawsuits as well:

  • Jardiance (empagliflozin)
  • Xigduo XR (dapagliflozin and metformin extended-release)
  • Invokamet (canagliflozin and metformin)
  • Glyxambi (empagliflozin and linagliptin)
  • Farxiga (dapagliflozin)

With a number of people experiencing these symptoms having to receive intensive care, it’s important that you understand the health risks associated with ketoacidosis; it can be life threatening.

If you or a loved one are experiencing or have experienced any of the above side effects after taking Invokana or any of the other drugs listed, you could have a lawsuit on your hands and could be entitled to compensation for medical malpractice. Please call The Brad Hendricks Law Firm today to discuss your rights and potential claim at (501) 221-0444 or toll-free at (800) 603-5100.

Contact Us Today | We are here to Help

The Brad Hendricks Law Firm proudly serves clients throughout Arkansas, including Arkadelphia, Benton, Conway, El Dorado, Fayetteville, Fort Smith, Hot Springs, Jonesboro, Little Rock, Pine Bluff, Texarkana, and West Memphis as well as numerous counties throughout the State of Arkansas, including Arkansas County, Baxter County, Benton County, Bradley County, Calhoun County, Clark County, Columbia County, Conway County, Crittenden County, Faulkner County, Garland County, Hempstead County, Hot Spring County, Izard County, Lawrence County, Lonoke County, Monroe County, Nevada County, Pike County, Poinsett County, Polk County, Pope County, Prairie County, Pulaski County, Saline County, Sharp County, Stone County, Washington County, White County, Woodruff County, and Yell County, and all other counties in the State of Arkansas.

Free Case Evaluation
800-603-5100

Contact Us

FAQS & VIDEO RESOURCES

Over $200 Million

RECOVERED FOR OUR CLIENTS